In the acute phase of acute myocardial infarction (3-8 h after onset of symptoms) an early transient increase in the creatine concentration of serum. saliva. and especially of urine can be observed. Due to the renal threshold, urine values give a much better discrimination between infarction patients and controls than do serum determination. In some patients secondary peaks of serum and urine creatine concentrations can be seen about 24-36 h after hospital admission. Intramuscular injections of 5·0 mL of a saline solution and muscular trauma interfere with the test. but with angina pectoris interference is absent or limited. Creatine leakage from myocardium is insufficient to explain the observed creatinuria in infarctions. and intact extra-cardiac tissues are believed to be involved in creatine release.
Diagnosis of the acute phase of a myocardial infarction (AMI) is based upon clinical history. changes in electrocardiogram (ECG). and the estimation of enzyme release from the infarcted myocardium. Clinical history is sometimes rather aspecific while ECG changes associated with irreversible myocardial ischaemia are late. Several investigators': 2 have criticised creatine kinase (CK) and the isoenzyme CKMB as sensitive and specific markers of AMI. Recently emergency thrombolytic and dilatation techniques were introduced in invasive cardiology in order to reduce infarction size. The success of these forms of therapy greatly depends on rapid and correct diagnosis of AMI. since salvage of jeopardised myocardium is more effective when the occluded artery can be recanalised during the first hours after AMI. 3 Adverse effects such as reperfusion arrhythmias or intracranial bleedings make these techniques undesirable to perform in cases which turn out to be falsely suspected of AMI.
Creatine is a constituent of human skeletal and cardiac muscle." As it is a small molecule (M, 131). creatine enters the plasma compartment very quickly after cellular lesions occur and is partly excreted in urine." Therefore, the possibility of using enzymatic creatine determinations in serum and urine as markers in early AMI diagnosis, was tested.
Materials and methods

REFERENCE POPULATION
A reference population of 138 apparently healthy subjects matched for sex and age was screened in order to study reference intervals of serum creatine concentration as determined with the enzymatic assay. Serum samples were obtained after an overnight fast and receiving a standard protein diet 5 d preceding blood collection. Urine creatine loads were calculated in 24 h collections in a Series of 20 healthy laboratory staff members. AMI Twenty-two patients (age 58·2±8·4 years) with proven myocardial infarction, diagnosed according to the WHO criteria," were monitored at the Coronary Care Unit during a period of 48 h with ECG and routine blood chemistry. In 12 patients arterial and bladder catheters were inserted for complications such as cardiogenic shock. severe dysrhythmias, and decompensation. In those patients serum and urine samples for CK and creatine analysis were obtained at intervals of 0·5 h during the first 12 h after admission and. consecutively. every 2 h during the next day. Serum samples of the other AMI patients were obtained every 2 h. and urine samples every 4 h during the first day. and every 6 h during the next day. At the time of blood collections samples of saliva were also aspirated in five of these patients in order to determine creatine concentrations.
ANGINA PECTORIS
Ten patients (age 56·4±6·5 years) with angina pectoris at rest or brought about by minimal exertion were followed during a new onset of their typical angina-like chest pain. Venous blood from these patients was obtained every 2 h after onset. while urine samples were taken after spontaneous micturition.
INTRAMUSCULAR INJECTIONS
Six healthy volunteers received an intramuscular (M. gluteus maximus) injection of a 0·9% NaCI solution. In three of them a 5·0 mL dose was injected. the others received a 2·0 mL dose. Blood samples were taken every 0·5 h during the first 6 h after injection. and further samples of urine after spontaneous micturition were collected during 24 h.
CREATINE I,OAD
Serum creatine levels and urine load were measured in seven healthy volunteers after oral administration of variable amounts of creatine (0·5-2·0 g) using the same time schedule of sampling as for the 1M injections.
METHODS
Serum and tissue creatine determinations were performed with the enzymatic assay of Suzuki? using creatine amidinohydrolase (EC 3.5.3.3). and sarcosine oxidase (EC 1.5.3.1). Urine creatine was performed by a modification of the Boehringer creatine-PAP reaction by Poortman et ai. 8 Total creatine kinase activity was assayed according to the method of Rosalki," and CKMB isoenzyme activity to the immunoprecipitation technique of Wicks et al.10 Creatine phosphate was enzymatically determined according to Heinz and Weisser. II All assays were done on a RA-l000analyser (Techniconv, Tarrytown. NY. USA) except for creatine phosphate determinations.
Skeletal muscle (n=3) and infarcted (n=3) as well as intact (1/=3) myocardium autopsy specimen obtained within 10 h after death were homogenised for 20 min in a Virtis 45 homogeniser. One gram wet weight tissue was mixed with 10 mL buffer containing to mmollL Tris (pH 7·4). 0·25 mollL sucrose. and 1 mmollL of (ethylenebis (oxyethylenenitrilo) tetraacetate. Cellular debris was removed by centrifugating twice at 4°C for 20 min (16 O()() g) and the clear supematant fluids were immediately analysed on their creatine and creatine phosphate content. and on creatine kinase activity (370C). 12 
Results
INTERfERENCES
Within the system of coupled enzymatic reactions used in the creatine determination the creatinase step is highly specific with respect to its substrate. Neither creatine phosphate nor 3-Me histidine. a marker of intensive muscular damage. interfere with the assay up to concentrations of 2·5 mmollL. In the following sarcosine oxidase reaction besides sarcosine also N-Me alanine and N-Et glycine show a relative activity for the enzyme.'? In order to judge interferences of these compounds urine and serum acute phase samples of AMI patients. as well as extracts of intact and infarcted left ventricle. and of skeletal muscle were analysed for amino acids by HPLC. Neither of the former molecules was found in sufficient quantities to influence significantly the enzymatic creatine assay.
REFERENCE VALUES
Age-and sex-related reference intervals for serum creatine levels as obtained by the enzymatic procedure were determined in a reference population (n= 138)and shown in Table 1 . Serum concentrations are significantly (P«)'()5) higher in women for each age group. while middle-age and elderly men have higher concentrations (P<O·05) than younger individuals. Since urinary concentrations of creatine may vary during the day the 24 h urine output (21±9'2I1mol) was calculated in a series of 20 healthy laboratory staff members on a normal protein diet.
ACUTE MYOCARDIAL INFARCTION
In the acute phase of AMI (n=22) early transient increases of serum creatine concentrations were observed in all patients with maximum concentrations of 95±24 umol/L (P<O·05) 2-4 h after the onset of retrosternal pain. In saliva samples collected from the patients at the moment of blood collection for creatine determination similar patterns to the one obtained in serum were seen. However, saliva determinations generally lacked analytical precision (CY 5-10%). In urine samples, a very sharp rise in creatine concentration was noticed, with peak concentrations of 4()()-4()()() umol/L, reached 3~min after the serum peak. Cumulative urinary output of 717± 328 umol were calculated over a period of 24 h after the onset of symptoms (P<O·()()l).
With respect to the use of creatine as an early marker for AMI diagnosis, time dependent curves of serum and urine concentrations of creatine were compared to sensitivity limits of the increase of CK enzyme activity after myocardial muscle injury. Figure 1 .... series of patients serum CK enzyme peak activity varied from 12 to 24 h after onset of AMI, while sensitivity limits were reached after a period of 4 to 8 h. By that time maximal serum creatine concentrations have been passed and creatine load has been largely filtrated and excreted since renal threshold levels are only slightly higher than serum reference values. Urinary samples obtained after 3 to 5 h after onset show significant elevated creatine concentrations, but the levels rapidly returned to the sensitivity limits within 1-3 h after maximal concentrations. In 15 out of 22 patients during the 2nd d of CCU observation a secondary urine peak was found without any clear evidence of its origin (Fig. 2) . In our series the cumulative creatine output within the first 24 h of infarction could not be significantlycorrelated with CK or CKMB peak height, nor with common algorithms for infarct sizing.14 .
After oral administration of 7·63 mmol of creatine in healthy volunteers (n=7) receiving a normal protein diet, 15±5% of the ingested amount was found back in urine. Cumulative creatine urine loads comparable to those obtained in AMI could only be induced in these individuals by oral intake of an average quantity of 5·34 mmol of creatine.
ANGINA PECTORIS
In 10 patients with unstable angina pectoris serum 57± 19 umol'L and urine «38 umol/L) creatine levels after an acute episode of chest pain were only slightly higher than reference values. but significantly lower than in AMI (P«Hll ).
INTRAMUSCULAR INJECTIONS
Intramuscular injections of 5·0 mL 0·9% NaCI solution in volunteers (n=3) revealed a marked increase in serum creatine concentration (76-230 umol/L) after a period of 1 h. The first urine samples after injection were also positive (380-1100 umol/L) while 3 h after serum peak value creatine levels returned to normal. During the experiment CK activities gradually increased to 20()-1500 U/L after 6 h. After intramuscular injection of 2·0 mL of ()·9% NaCI only mild increases of creatine concentration were noticed. not at all comparable with AMI (n=3). Creatine and creatine phosphate concentration and CK activities in skeletal muscle (n=6). and intact (n=3) as well as diseased myocardium (n=3) were compared. and relative losses were calculated. The results of tissue analysis are summarised in Table 2 . A reduction of the three compounds of interest in infarcted tissue to about 4()'Yo was observed,
Discussion
In the reference population. serum creatine concentrations after a normal protein diet arc characterised by a relative small reference interval. Between the ages of 20 and 70. reference ranges are quite constant; values for women are about 8 umol/L higher than for men. In urine. creatine concentrations are variable. but low due to the renal threshold which was calculated to be 68± 12 ",moltL which is slightly above the physiological serum concentration.
In the course of an AMI both serum and salivary creatine levels show an early, transient increase. However. differences between normal and AMI samples arc not pronounced. and there is some overlap with normal values when samples are not taken at the exact moment. Determinations of creatinuria in the first urine samples after onset of symptoms result in a much better distinction between patients and controls than serum creatine determinations do. This loss of creatine is rather specific for AMI. since this phenomemon is not seen or only to a limited extent in clinical situations with similar symptomatology like unstable angina pectoris. Relative loss of creatine from infarcted autopsy myocardial tissue was comparable with the relative loss of CK. a 88 kD protein. As a consequence this creatine loss can be regarded as a non-specific leakage process. but from the quantitative point of view it cannot explain the large amounts of creatine found in urine after AMI. corresponding sometimes to more than twice the creatine content of a normal heart or with the total creatine (including phosphate) content of about ±300 g of myocardial tissue. Lack of correlation between serum CK activity, generally accepted as a parameter for infarction sizing. 15 and unexpected high creatine loss after AMI suggests the latter originates from extra-cardiac sources.
Multistep de novo synthesis requires both kidney and liver enzymes and is insufficient to produce such large quantities of creatine in a short period of time. Earlier high creatine release after relatively small skeletal muscle trauma was reported, and intact muscle was thought to be the source of the excess amount of creatinuria." Skeletal muscle containing about 1 mol of creatine can be regarded as a possible donor organ for creatine in the early stages of AMI.
Secondary peaks observed during the 2nd d of hospital admission may be the expression of small reinfaretions which cannot be detected by classical heart enzyme diagnosis, but since similar late peaks have also been reported after skeletal muscle trauma," it is possible that a signal (hormonal?) at present not understood, may account for. or trigger, these as well as primary peaks in AMI.
Determining creatine in serum and especially in urine of patients with tentatively diagnosed AMI offers a promising alternative for a quick and relatively simple biochemical diagnosis. 17 The test becomes positive earlier than any other currently used biochemical or electrocardiographic marker. Muscular trauma may interfere with the interpretation of data on creatine, but this is also the case for serum CK and myoglobin determinations. However. muscular trauma is clinically detectable and a combination of trauma and AMI remains an exception. In coronary heart disease, atypical CK forms could be detected in up to 13% of the patients." So creatine determinations may be helpful for AMI diagnosis in this high risk population since atypical forms are known to interfere with immuno-inhibition methods for CK-MB assays.
